In one patient with AMVP and mildly reduced LVEF, the repeat CMR showed disappearance of the grade 1 mitral regurgitation at baseline under therapy with beta-blockers and low-dose ACE-inhibitors. The gene discussed is ACE; the disease is mitral valve insufficiency.